Friday, 15 Dec 2017

Education/ACR/EULAR

Datesort ascending Type Title Save
05 Nov 2017 Social RT @psufka: My friend @Linherski's Goutpro learning tool for trainees. #ACR17 @RheumNow #117 https://t.co/6s1lIP9AZe
05 Nov 2017 ACR Video Dr. Cassandra Calabrese: Efficacy of Flu Vaccine on RA Patients
05 Nov 2017 ACR Video Dr. Artie Kavanaugh: New Treatments, Outcome Measures for PsA
05 Nov 2017 ACR Video Dr. Rachel Tate and Dr. Brooke Mills: Pregnancy and Arthritis
05 Nov 2017 ACR Video Dr. Gregg Silverman: The Microbiome and SLE
05 Nov 2017 Social RT @DrRachelTate: What data are you reporting for MACRA? #ACR17 @RheumNow
05 Nov 2017 News RA and Cardiac Co-Morbidities
05 Nov 2017 News Complementopathies: Redefining Old Diseases
05 Nov 2017 ACR Video Dr. Olga Petryna: FRAME Study
05 Nov 2017 ACR Video Dr. Jack Cush: New Biologics, Pregnancy in AS/SpA, JAK, Gout, Psoriatic Arthritis and More
05 Nov 2017 ACR Video Dr. Paul Sufka: Rheumatology Journal Club, Tech Topics at ACR
05 Nov 2017 ACR Video Dr. Olga Petryna: TKR and Role of Socioeconomic Factors in Outcomes
05 Nov 2017 Social RT @philipcrobinson: Super excited about this talk on checkpoint inhibitor immune mediated disease #ACR17 https://t.co/E58KSa3T6k
05 Nov 2017 Social RT @_connectedcare: Current targets of Cancer Immunotherapy #ACR17 @rheumnow https://t.co/A1qyfLaFFM
05 Nov 2017 Social RT @_connectedcare: PD1/PDL1 checkpoint helps turn OFF T-cells Cancer cells can express PDL1. Many tumours are “PDL-omas” #acr17 @RheumNow
05 Nov 2017 Social RT @CherylKoehn: @ACEJointHealth @jesdaile @Roche Dr Esdaile highlights gap in med school curricula - only 20 hrs of ed provided on MSK! #…
05 Nov 2017 News The Red Eye in the Rheumatology Patient
05 Nov 2017 Social RT @philipcrobinson: Immune checkpoint drugs approved and on the way. There are many more on the way. #ACR17 @RheumNow https://t.co/TOJeQBQ…
05 Nov 2017 Social RT @CCalabreseDO: Lots of checkpoint/IRAE action at #ACR17 Working to increase knowledge &awareness! @LCalabreseDO @PGrivasMDPhD @MosheOrns…
05 Nov 2017 Social RT @CCalabreseDO: Clifton O. Bingham III: Many potential immunologic checkpoint targets for therapies = more IRAEs! @RheumNow #ACR17 https:…